Antimycobacterial Drugs Market

Future Market Insights

Antimycobacterial Drugs Market

Key Insight

The antimycobacterial drugs market is projected to grow from USD 4,200 million in 2025 to USD 5,924.5 million by 2035, at a CAGR of 3.5%. By product type, first-line TB drugs will lead with a 40.5% market share, while by application, pulmonary TB will dominate with a 62% share in 2025.

December 03, 2025

Anurag Sharma

250 Pages

Cite this Report

Antimycobacterial Drugs Market

https://www.futuremarketinsights.com/reports/antimycobacterial-drugs-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Fujifilm Toyama
GSK plc
Janssen (J&J)
L'Oréal
Viatris Inc. (Mylan)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Antimycobacterial Drugs Market

Key Players

Similar Industry Reports